News & Discoveries

December 20, 2022

UCSF Researchers Identify the Cellular Source of Recurrent GliomaThrough decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.

December 20, 2022

While we sleep, our brains process our daily actions to create motor memory, which makes physical acts such as throwing a basketball subconscious.

November 30, 2022

38 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.

November 28, 2022

UCSF Experts Address CTAD Conference on Pharma-Free Intervention; Patient Data Repository; First Trial of svPPA TreatmentUCSF Experts Present Research at the Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Francisco.

November 21, 2022

UCSF-VA Study Shows Psychiatric Disorders Increase Risks for Deaths, HospitalizationsRisk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.

November 15, 2022

Discovery May Point to New Therapeutic Approach for Common Neurodegenerative DisordersThe brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer’s disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. A new study shows that these tangles and plaques are driven by the same amyloid beta (Aß) and tau prions as Alzheimer’s disease.

November 10, 2022

UCSF Experts to Highlight Cutting Edge Advances and Discoveries at World’s Largest Meeting Devoted to NeuroscienceBrain implants for speech, neurological effects of COVID-19, and motor recovery after stroke are among the topics that researchers from UCSF will be presenting at this year’s annual meeting of the Society for Neuroscience.

November 01, 2022

UCSF Researchers Drive Efforts to Recruit More Black, Latinx, Asian and American Indian ParticipantsA $147 million grant will expand diversity among Alzheimer’s disease research participants, and involve partners from UCSF, the San Francisco VA Medical Center, and the Northern California Institute for Research and Education.

October 27, 2022

After Don Onken suffered a stroke at 78, a quick response by doctors at the UCSF Medical Center at Parnassus Heights helped him get back on his feet quickly – and back to the golf course.

October 17, 2022

UCSF Researchers Rescue Cognitive Function by Blocking Molecular Stress Response with ISRIBA small molecule called ISRIB that was identified at UCSF can reverse the neuronal and cognitive effects of concussion in mice weeks after an injury occurred, new research found.